TP53 and rheumatoid arthritis: Because mutant p53 has a longer half-life, its expression in the synovium is increased in RA [55] and FLSs may be protected from apoptosis by dominant-negative p53 mutations, which may contribute to FLS invasiveness [56] (Figure 2).